Unicycive Therapeutics Inc (UNCY): Next-Year EPS Estimate 514.49%
As of 2026-06-04, Unicycive Therapeutics Inc (UNCY) has a next-year EPS growth estimate of 514.49%.
UNCY was first flagged by our screen on 2026-05-28, when analyst consensus for its next-year EPS growth was revised from 543.74% to 543.90%. Current-year growth is projected at 14.40%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 514.49%
- EPS growth this year
- 14.40%
- EPS next quarter (est)
- -$0.55
- Last price
- $7.43
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 514.49% | 14.40% | -$0.55 | $7.43 |
| 2026-06-03 | 514.49% | 14.40% | -$0.55 | $7.20 |
| 2026-06-02 | 543.90% | 13.20% | -$0.57 | $7.23 |
| 2026-06-01 | 543.90% | 13.20% | -$0.57 | $7.60 |
| 2026-05-31 | 543.90% | 13.20% | -$0.57 | $7.38 |
| 2026-05-28 | 543.90% | 13.20% | -$0.57 | $7.02 |
| 2026-05-27 | 543.74% | 13.17% | -$0.57 | $7.07 |
| 2026-05-26 | 543.74% | 13.17% | -$0.57 | $7.06 |
| 2026-05-25 | 543.74% | 13.17% | -$0.57 | $8.08 |
| 2026-05-24 | 543.74% | 13.17% | -$0.57 | $8.08 |
| 2026-05-21 | 543.74% | 13.17% | -$0.57 | $7.63 |
| 2026-05-20 | 543.74% | 13.17% | -$0.57 | $7.74 |
| 2026-05-19 | 543.74% | 13.17% | -$0.57 | $7.73 |
| 2026-05-18 | 543.74% | 13.17% | -$0.57 | $8.15 |
| 2026-05-17 | 543.74% | 13.17% | -$0.57 | $8.26 |
| 2026-05-14 | 572.23% | 18.63% | -$0.54 | $8.56 |
| 2026-05-13 | 572.23% | 18.63% | -$0.54 | $8.44 |
| 2026-05-12 | 547.33% | 13.37% | -$0.53 | $8.17 |
| 2026-05-11 | 1230.81% | 64.27% | -$0.46 | $7.95 |
| 2026-05-10 | 1230.81% | 64.27% | -$0.46 | $7.94 |
| 2026-05-07 | 1230.81% | 64.27% | -$0.46 | $7.86 |
| 2026-05-06 | 1230.81% | 64.27% | -$0.46 | $8.13 |
| 2026-05-05 | 1230.81% | 64.27% | -$0.46 | $8.08 |
| 2026-05-04 | 1230.81% | 64.27% | -$0.46 | $7.98 |
| 2026-05-03 | 1230.81% | 64.27% | -$0.46 | $7.67 |
| 2026-04-30 | 6686.39% | 92.66% | -$0.36 | $7.66 |
| 2026-04-29 | 6686.39% | 92.66% | -$0.36 | $7.16 |
| 2026-04-28 | 6686.39% | 92.66% | -$0.36 | $7.17 |
| 2026-04-27 | 6686.39% | 92.66% | -$0.36 | $7.23 |
| 2026-04-26 | 6686.39% | 92.66% | -$0.36 | $7.29 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Unicycive Therapeutics Inc's next-year EPS growth estimate?▾
As of 2026-06-04, Unicycive Therapeutics Inc (UNCY) has a next-year EPS growth estimate of 514.49%, based on analyst consensus.
When was the latest EPS estimate revision for UNCY?▾
The most recent revision occurred on 2026-06-03, when analysts adjusted the next-year EPS growth estimate from 543.90% to 514.49%.
What sector and industry does Unicycive Therapeutics Inc belong to?▾
Unicycive Therapeutics Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. UNCY appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Unicycive Therapeutics Inc (UNCY) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports